Pulling SEC filings + quote and writing the call…

Vera Bradley, Inc.
Next earnings Sep 9, 2026 · consensus $-0.08 EPS, $66.6M rev
Last earnings +8.8% on 2026-06-11
A debt-free brand trading below book, but revenue halved in 4 years and cash is still burning — value trap, not value.
Revenue (FY2026) $270M · FY2026
Vera Bradley is in a structural, multi-year decline that the numbers leave no room to argue with. Revenue has fallen every single year — $540M (FY22) → $500M → $384M → $319M → $270M (FY26) — a ~50% collapse over four years, including -15.4% in the latest year. The company has lost money in three of the last four years (-$59.7M, -$62.2M, -$47.8M), gross profit fell -21.3% even as gross margin held at 46.4%, and operating margin is deeply negative at -11.8%. ROE is -36.3%. Critically, the business is consuming cash: operating cash flow was -$9.97M and cash fell 35% to just $18.5M. At that burn rate the cash cushion is finite, and capex was already slashed -68% to $3.29M, which flatters cash flow but signals retrenchment, not investment in growth.
The MD&A frames FY2026 around 'Project Sunshine,' a turnaround built on brand collaborations (Disney, Anthropologie, Harry Potter) and 'Outlet 2.0,' alongside closing twelve underperforming full-line stores. Management claims the Direct segment is 'beginning to resonate,' but there is no quantified comparable-sales improvement in the provided data to corroborate that — revenue still fell double digits. The Risk Factors are explicit that this is discretionary spend exposed to consumer confidence, and they flag direct tariff exposure on China/Mexico/Canada sourcing, which threatens the one bright spot, gross margin. A turnaround on a shrinking, unprofitable base with a thin $18.5M cash balance is unproven and fragile.
Is VRA a buy? The one-page verdict, explained →
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | $540M | $500M | $384M | $319M | $270M |
| Gross profit | $288M | $239M | $204M | $159M | $125M |
| Operating income | $26.9M | -$94.9M | $11.6M | -$28.8M | -$31.9M |
| Net income | $17.8M | -$59.7M | $7.84M | -$62.2M | -$47.8M |
| Diluted EPS | $0.52 | -$1.90 | $0.25 | -$2.15 | -$1.71 |
| Net margin | 3.3% | -11.9% | 2.0% | -19.5% | -17.7% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q1 FY27: Direct segment improving but overall sales still declining
Q1 FY27: Direct segment improving but overall sales still declining
Annual meeting vote results filed; routine governance matters
Annual proxy: board nominees, exec pay and say-on-pay up for shareholder vote
Annual proxy: board nominees, exec pay and say-on-pay up for shareholder vote
Adopted shareholder rights plan (poison pill), a takeover defense vs activists
FY26: revenue -15% to $270M, net loss narrowed to $47.8M; launched Project Sunshine
Executive/board leadership change disclosed
Reported FY26 results: revenue -15% to $270M, net loss $47.8M
Sources: SEC EDGAR (CIK 0001495320, latest 10-Q filed 2026-06-11) · EODHD · Proprietary analysis · as of 6/30/2026, 11:43:38 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 7:43 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 2 open-market buys · 0 sales
| 2026-06-24 | Dely Mark C CHIEF ADMINISTRATIVE OFFICER | Tax | 13.7K @ $3.84 | $52.6K |
| 2026-06-12 | Bickley Ian Chief Executive Officer | Buy | 28.9K @ $3.87 | $112K |
| 2026-06-12 | Layding Martin Chief Financial Officer | Tax | 14.0K @ $3.46 | $48.4K |
| 2026-06-12 | Layding Martin Chief Financial Officer | Tax | 29.4K @ $3.46 | $102K |
| 2026-06-12 | Meslow Andrew Director | Buy | 24.9K @ $3.73 | $93.0K |
| 2026-06-08 | Dely Mark C CHIEF ADMINISTRATIVE OFFICER | Tax | 1.01K @ $3.08 | $3.10K |
| 2026-06-08 | Dely Mark C CHIEF ADMINISTRATIVE OFFICER | Award | 9.11K | |
| 2026-06-08 | Dely Mark C CHIEF ADMINISTRATIVE OFFICER | Tax | 2.91K @ $3.08 | $8.97K |
| 2026-04-03 | Rodriguez Jessica Director | Award | 25.1K | |
| 2026-04-03 | CASHMAN KRISTINA K Director | Award | 25.1K | |
| 2026-04-03 | Layding Martin Chief Financial Officer | Award | 88.5K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median